Skip to content
10-Q

Quarterly Report

F-STAR THERAPEUTICS, INC.

0000950170-22-016675

← back to feed
Filed
Aug 11, 2022 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted Q2 2022 · Jun 30, 2022 21.57M sh
Shares Diluted Q2 2022 · Jun 30, 2022 21.33M sh
Shares Diluted Q2 2022 · Jun 30, 2021 17.02M sh
Shares Diluted Q2 2022 · Jun 30, 2021 13.08M sh
Capex Q2 2022 · Jun 30, 2022 $235K
Capex Q2 2022 · Jun 30, 2021 $658K
Operating Cash Flow Q2 2022 · Jun 30, 2022 −$28.15M
Operating Cash Flow restated Q2 2022 · Jun 30, 2021 −$23.35M
Long Term Debt Q2 2022 · Jun 30, 2022 $9.4M
Long Term Debt Q2 2022 · Dec 31, 2021 $9.61M
Short Term Debt Q2 2022 · Jun 30, 2022 $353K
Cash And Equivalents Q2 2022 · Jun 30, 2022 $52.96M
Cash And Equivalents Q2 2022 · Dec 31, 2021 $78.55M
Stockholders Equity Q2 2022 · Jun 30, 2022 $71.64M
Stockholders Equity Q2 2022 · Mar 31, 2022 $88.16M
Stockholders Equity Q2 2022 · Dec 31, 2021 $96.86M
Stockholders Equity restated Q2 2022 · Jun 30, 2021 $99.24M
Stockholders Equity restated Q2 2022 · Mar 31, 2021 $34.97M
Stockholders Equity Q2 2022 · Dec 31, 2020 $42.99M
Current Liabilities Q2 2022 · Jun 30, 2022 $15.32M
Current Liabilities Q2 2022 · Dec 31, 2021 $12.14M
Total Liabilities Q2 2022 · Jun 30, 2022 $29.01M
Total Liabilities Q2 2022 · Dec 31, 2021 $26.16M
Current Assets Q2 2022 · Jun 30, 2022 $64.86M
Current Assets Q2 2022 · Dec 31, 2021 $84.74M
Total Assets Q2 2022 · Jun 30, 2022 $100.64M
Total Assets Q2 2022 · Dec 31, 2021 $123.02M
Eps Diluted Q2 2022 · Jun 30, 2022 −$0.88
Eps Diluted Q2 2022 · Jun 30, 2022 −$1.46
Eps Diluted Q2 2022 · Jun 30, 2021 −$0.91
Eps Diluted Q2 2022 · Jun 30, 2021 −$1.93
Eps Basic Q2 2022 · Jun 30, 2022 −$0.88
Eps Basic Q2 2022 · Jun 30, 2022 −$1.46
Eps Basic Q2 2022 · Jun 30, 2021 −$0.91
Eps Basic Q2 2022 · Jun 30, 2021 −$1.93
Sga Expense Q2 2022 · Jun 30, 2022 $7.46M
Sga Expense Q2 2022 · Jun 30, 2022 $13.16M
Sga Expense Q2 2022 · Jun 30, 2021 $6.5M
Sga Expense Q2 2022 · Jun 30, 2021 $12.93M
Rd Expense Q2 2022 · Jun 30, 2022 $8.72M
Rd Expense Q2 2022 · Jun 30, 2022 $16.76M
Rd Expense restated Q2 2022 · Jun 30, 2021 $8.29M
Rd Expense restated Q2 2022 · Jun 30, 2021 $15.42M
Net Income Q2 2022 · Jun 30, 2022 −$18.99M
Net Income Q2 2022 · Jun 30, 2022 −$31.08M
Net Income restated Q2 2022 · Jun 30, 2021 −$15.5M
Net Income restated Q2 2022 · Jun 30, 2021 −$25.23M
Operating Income Q2 2022 · Jun 30, 2022 −$16.18M
Operating Income Q2 2022 · Jun 30, 2022 −$27.37M
Operating Income restated Q2 2022 · Jun 30, 2021 −$14.79M
Operating Income restated Q2 2022 · Jun 30, 2021 −$25.44M
Revenue Q2 2022 · Jun 30, 2022 $0
Revenue Q2 2022 · Jun 30, 2022 $2.55M
Revenue Q2 2022 · Jun 30, 2021 $0
Revenue Q2 2022 · Jun 30, 2021 $2.92M